Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Equity Holding : 68.62% | F&O Holdings : 0.00%| Foreign Equity Holdings : 31.23%| Total : 99.85%

No of Stocks : 45 (Category Avg - 54.20) | Large Cap Investments : 27.67%| Mid Cap Investments : 16.28% | Small Cap Investments : 1.6% | Other : 54.3%

Portfolio Summary (as on 31st Oct,2025)

Particulars	This Scheme	Category
No. of Stocks	45	76.28
Top 5 Stock Weight	34.43%	37.21%
Top 10 Stock Weight	54.94%	54.41%
Top 3 Sector Weight	99.04%	34.22%

Category - Index Funds/ETFs

Particulars	This Scheme	Category
Average mcap (Cr)	22038.31	113148.29
Holdings in large cap stocks	27.67%	50.9%
Holdings in mid cap stocks	16.28%	15.68%
Holdings in small cap stocks	1.6%	8.49%

Category - Index Funds/ETFs

Top 10 Stocks holding in Portfolio (as on 31st Oct,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	187.4	11.16%	0.27%	13.13% (Nov 2024)	10.84% (Aug 2025)	1.11 L	-0.31 k
Max Healthcare Institute Ltd.	Hospital	103.1	6.14%	-0.03%	7.08% (Jun 2025)	5.85% (Nov 2024)	89.81 k	-0.25 k
Cipla Ltd.	Pharmaceuticals	98	5.84%	-0.21%	6.36% (Aug 2025)	5.7% (Dec 2024)	65.30 k	-0.18 k
ELI LILLY ORD SHS	Foreign equity	96.5	5.75%	0.50%	6.34% (Feb 2025)	4.86% (May 2025)	1.26 k	0.00
Divis Laboratories Ltd.	Pharmaceuticals	93	5.54%	0.70%	6.03% (May 2025)	4.84% (Sep 2025)	13.80 k	-38.00
Apollo Hospitals Enterprises Ltd.	Hospital	89.3	5.32%	0.01%	5.43% (Aug 2025)	4.75% (Feb 2025)	11.62 k	-32.00
Dr. Reddys Laboratories Ltd.	Pharmaceuticals	80.8	4.81%	-0.28%	5.76% (Dec 2024)	4.81% (Oct 2025)	67.46 k	-0.19 k
Johnson & Johnson	Foreign equity	63	3.75%	-0.05%	3.8% (Sep 2025)	2.84% (Dec 2024)	3.76 k	0.00
Fortis Healthcare Ltd.	Hospital	58	3.45%	0.06%	3.45% (Oct 2025)	2.32% (Jan 2025)	56.67 k	-0.16 k
AbbVie Inc	Foreign equity	53.4	3.18%	-0.31%	3.49% (Sep 2025)	2.49% (Nov 2024)	2.76 k	0.00

- indicates change in weight in the portfolio. # indicates a new entry.

View complete holding

Complete equity Portfolio (as on 31st Oct,2025)

None
Sector
M-Cap

Help me understand this table

Stock Invested in	Sector	Sector Total	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty	M-Cap	GroupName
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	51.31	187.4	11.16%	0.27%	13.13% (Nov 2024)	10.84% (Aug 2025)	1.11 L	-0.31 k	Large Cap	27.67
Max Healthcare Institute Ltd.	Hospital	16.5	103.1	6.14%	-0.03%	7.08% (Jun 2025)	5.85% (Nov 2024)	89.81 k	-0.25 k	Other	54.3
Cipla Ltd.	Pharmaceuticals	51.31	98	5.84%	-0.21%	6.36% (Aug 2025)	5.7% (Dec 2024)	65.30 k	-0.18 k	Large Cap	27.67
ELI LILLY ORD SHS	Foreign equity	31.23	96.5	5.75%	0.50%	6.34% (Feb 2025)	4.86% (May 2025)	1.26 k	0.00	Other	54.3
Divis Laboratories Ltd.	Pharmaceuticals	51.31	93	5.54%	0.70%	6.03% (May 2025)	4.84% (Sep 2025)	13.80 k	-38.00	Large Cap	27.67
Apollo Hospitals Enterprises Ltd.	Hospital	16.5	89.3	5.32%	0.01%	5.43% (Aug 2025)	4.75% (Feb 2025)	11.62 k	-32.00	Mid Cap	16.28
Dr. Reddys Laboratories Ltd.	Pharmaceuticals	51.31	80.8	4.81%	-0.28%	5.76% (Dec 2024)	4.81% (Oct 2025)	67.46 k	-0.19 k	Other	54.3
Johnson & Johnson	Foreign equity	31.23	63	3.75%	-0.05%	3.8% (Sep 2025)	2.84% (Dec 2024)	3.76 k	0.00	Other	54.3
Fortis Healthcare Ltd.	Hospital	16.5	58	3.45%	0.06%	3.45% (Oct 2025)	2.32% (Jan 2025)	56.67 k	-0.16 k	Other	54.3
AbbVie Inc	Foreign equity	31.23	53.4	3.18%	-0.31%	3.49% (Sep 2025)	2.49% (Nov 2024)	2.76 k	0.00	Other	54.3
Lupin Ltd.	Pharmaceuticals	51.31	51.8	3.08%	-0.03%	3.82% (Dec 2024)	3.06% (Aug 2025)	26.37 k	-73.00	Large Cap	27.67
Torrent Pharmaceuticals Ltd.	Pharmaceuticals	51.31	48.7	2.90%	-0.14%	3.1% (Jul 2025)	2.42% (Dec 2024)	13.68 k	-38.00	Mid Cap	16.28
Laurus Labs Ltd.	Pharmaceuticals	51.31	38.6	2.30%	0.20%	2.3% (Oct 2025)	1.44% (Feb 2025)	40.50 k	-0.11 k	Other	54.3
Aurobindo Pharma Ltd.	Pharmaceuticals	51.31	34.4	2.05%	0.03%	2.56% (Nov 2024)	1.9% (Aug 2025)	30.18 k	-83.00	Large Cap	27.67
Mankind Pharma Ltd.	Pharmaceuticals	51.31	34.1	2.03%	-0.12%	2.33% (May 2025)	1.8% (Jan 2025)	14.30 k	-40.00	Other	54.3
NOVARTIS AG	Foreign equity	31.23	32.6	1.94%	-0.14%	2.08% (Sep 2025)	1.57% (Dec 2024)	2.97 k	0.00	Other	54.3
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals	51.31	30.8	1.84%	-0.12%	2.1% (Jul 2025)	1.41% (Feb 2025)	16.29 k	-45.00	Mid Cap	16.28
Abbott Laboratories	Foreign equity	31.23	29.8	1.78%	-0.21%	2.05% (Feb 2025)	1.59% (Nov 2024)	2.72 k	0.00	Other	54.3
Merck & Co Inc Shs	Foreign equity	31.23	29.9	1.78%	-0.02%	2.14% (Jan 2025)	1.59% (May 2025)	3.92 k	0.00	Other	54.3
Thermo Fisher Scientific Inc	Foreign equity	31.23	29.8	1.77%	0.21%	1.95% (Jan 2025)	1.26% (May 2025)	591.00	0.00	Other	54.3
Zydus Lifesciences Ltd.	Pharmaceuticals	51.31	28.3	1.69%	-0.07%	1.87% (Nov 2024)	1.66% (Apr 2025)	29.05 k	-80.00	Mid Cap	16.28
Alkem Laboratories Ltd.	Pharmaceuticals	51.31	26.6	1.59%	-0.03%	1.65% (Dec 2024)	0% (Nov 2024)	4.83 k	-13.00	Mid Cap	16.28
Intuitive Surgical	Foreign equity	31.23	26.6	1.58%	0.21%	1.74% (Jan 2025)	1.37% (Sep 2025)	561.00	0.00	Other	54.3
Biocon Ltd.	Pharmaceuticals	51.31	23	1.37%	0.07%	1.46% (Jul 2025)	0.99% (Feb 2025)	61.76 k	-0.17 k	Mid Cap	16.28
Amgen	Foreign equity	31.23	22.3	1.33%	0.04%	1.42% (Feb 2025)	1.14% (Dec 2024)	841.00	0.00	Other	54.3
# Novo Nordisk A/S	Foreign equity	31.23	22	1.31%	0.00%	0% (Nov 2025)	0% (Nov 2025)	5.01 k	0.00	Other	54.3
Gilead Sciences	Foreign equity	31.23	20.7	1.23%	0.05%	1.23% (Oct 2025)	0.89% (Nov 2024)	1.95 k	0.00	Other	54.3
Ipca Laboratories Ltd.	Pharmaceuticals	51.31	20.5	1.22%	-0.11%	1.68% (Dec 2024)	1.22% (Oct 2025)	16.11 k	-44.00	Other	54.3
Danaher Corporation	Foreign equity	31.23	19.2	1.15%	0.06%	1.24% (Jan 2025)	1.01% (May 2025)	1.01 k	0.00	Other	54.3
Stryker Corporation	Foreign equity	31.23	17	1.01%	-0.08%	1.15% (Jan 2025)	1.01% (Dec 2024)	538.00	0.00	Other	54.3
Gland Pharma Ltd.	Pharmaceuticals	51.31	16.5	0.98%	-0.07%	1.07% (Jul 2025)	0.77% (Apr 2025)	8.56 k	-23.00	Other	54.3
Medtronic Plc	Foreign equity	31.23	16.1	0.96%	-0.08%	1.04% (Sep 2025)	0.84% (Dec 2024)	2.00 k	0.00	Other	54.3
Vertex Pharmaceuticals	Foreign equity	31.23	15.2	0.90%	0.04%	1.06% (Feb 2025)	0.85% (Dec 2024)	402.00	0.00	Other	54.3
Narayana Hrudayalaya Ltd.	Hospital	16.5	14.5	0.86%	-0.02%	1.11% (Jun 2025)	0% (Nov 2024)	8.26 k	-23.00	Small Cap	1.6
Piramal Pharma Ltd.	Pharmaceuticals	51.31	13.8	0.82%	0.01%	1.15% (Dec 2024)	0% (Nov 2024)	69.08 k	-0.19 k	Other	54.3
Syngene International Ltd.	Healthcare research, analytics & technology	0.81	13.6	0.81%	0.01%	1.31% (Nov 2024)	0.8% (Sep 2025)	20.94 k	-58.00	Mid Cap	16.28
GlaxoSmithKline Pharmaceuticals Ltd.	Pharmaceuticals	51.31	12.8	0.76%	-0.04%	1.07% (May 2025)	0.62% (Jan 2025)	4.89 k	-13.00	Mid Cap	16.28
Ajanta Pharma Limited	Pharmaceuticals	51.31	12.5	0.74%	-0.01%	1.02% (Nov 2024)	0.74% (Oct 2025)	5.05 k	-14.00	Small Cap	1.6
Global Health Ltd.	Hospital	16.5	12.2	0.73%	-0.02%	0.78% (Aug 2025)	0.62% (Jan 2025)	9.31 k	-26.00	Other	54.3
Suven Pharmaceuticals Ltd.	Pharmaceuticals	51.31	10	0.59%	-0.13%	1.02% (Nov 2024)	0.59% (Oct 2025)	13.25 k	-37.00	Other	54.3
Regeneron Pharmaceuticals	Foreign equity	31.23	9.7	0.58%	0.07%	0.64% (Feb 2025)	0.43% (May 2025)	167.00	0.00	Other	54.3
Becton Dickinson and Co	Foreign equity	31.23	7.1	0.42%	-0.04%	0.61% (Jan 2025)	0.41% (May 2025)	448.00	0.00	Other	54.3
Agilent Technologies Inc	Foreign equity	31.23	5.8	0.34%	0.03%	0.37% (Jan 2025)	0.24% (Apr 2025)	445.00	0.00	Other	54.3
Iqvia Holdings	Foreign equity	31.23	5.2	0.31%	0.03%	0.31% (Jan 2025)	0.21% (May 2025)	271.00	0.00	Other	54.3
ILLUMINA	Foreign equity	31.23	2.7	0.16%	0.03%	0.18% (Nov 2024)	0.1% (Apr 2025)	247.00	0.00	Other	54.3

- indicates change in weight in the portfolio. # indicates a new entry.

New Stocks added in Portfolio (in 1 month period ending 31st Oct,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
No new entrants in the portfolio in the last month.

Stocks removed from Portfolio (in 1 month period ending 31st Oct,2025)

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
No complete exits in the portfolio in the last month.

Trend in stock holdings (Top 15 Holding)

Stock	Oct 2025	Sep 2025	Aug 2025	Jul 2025	Jun 2025	May 2025	Apr 2025	Mar 2025	Feb 2025	Jan 2025	Dec 2024	Nov 2024	Oct 2024
Sun Pharmaceutical Industries Ltd.	11.16%	10.89%	10.84%	11.45%	11.47%	12.29%	13.06%	12.66%	11.92%	12.37%	12.86%	13.13%	13.34%
Max Healthcare Institute Ltd.	6.14%	6.17%	6.36%	6.77%	7.08%	6.68%	6.34%	6.39%	5.93%	6.10%	6.23%	5.85%	5.95%
Cipla Ltd.	5.84%	6.05%	6.36%	6.14%	6.07%	5.87%	6.04%	5.74%	5.76%	5.74%	5.70%	6.19%	6.12%
Divis Laboratories Ltd.	5.54%	4.84%	5.19%	5.51%	5.80%	6.03%	5.40%	5.12%	5.10%	4.93%	5.17%	5.67%	5.29%
Dr. Reddys Laboratories Ltd.	4.81%	5.09%	5.21%	5.19%	5.35%	5.58%	5.14%	5.14%	5.08%	5.26%	5.76%	5.39%	5.59%
Apollo Hospitals Enterprises Ltd.	5.32%	5.31%	5.43%	5.28%	5.20%	5.29%	5.22%	5.01%	4.75%	5.07%	5.22%	5.28%	5.31%
Lupin Ltd.	3.08%	3.11%	3.06%	3.08%	3.16%	3.41%	3.55%	3.58%	3.39%	3.51%	3.82%	3.59%	3.75%
Torrent Pharmaceuticals Ltd.	2.90%	3.04%	2.99%	3.10%	2.88%	2.87%	2.92%	2.85%	2.56%	2.45%	2.42%	2.59%	2.44%
Fortis Healthcare Ltd.	3.45%	3.39%	3.17%	2.94%	2.78%	2.65%	2.50%	2.46%	2.34%	2.32%	2.51%	2.49%	2.30%
Aurobindo Pharma Ltd.	2.05%	2.02%	1.90%	2.08%	2.12%	2.29%	2.39%	2.33%	2.16%	2.26%	2.48%	2.56%	2.77%
Mankind Pharma Ltd.	2.03%	2.15%	2.17%	2.22%	2.05%	2.33%	2.27%	2.14%	2.02%	1.80%	2.05%	1.97%	2.01%
Zydus Lifesciences Ltd.	1.69%	1.76%	1.75%	1.71%	1.78%	1.79%	1.66%	1.71%	1.72%	1.80%	1.74%	1.87%	1.89%
Laurus Labs Ltd.	2.30%	2.10%	2.13%	2.14%	1.81%	1.63%	1.57%	1.60%	1.44%	1.51%	1.50%	1.53%	1.29%
Glenmark Pharmaceuticals Ltd.	1.84%	1.96%	1.92%	2.10%	1.77%	1.57%	1.45%	1.58%	1.41%	1.52%	1.61%	1.66%	1.80%
Alkem Laboratories Ltd.	1.59%	1.62%	1.57%	1.47%	1.47%	1.63%	1.59%	1.54%	1.52%	1.57%	1.65%	-	-